Premier (NASDAQ:PINC) Updates FY 2025 Earnings Guidance

Premier (NASDAQ:PINC) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.160-1.280 for the period, compared to the consensus estimate of 2.220. The company issued revenue guidance of $930.0 million-$1.0 billion, compared to the consensus revenue estimate of $1.3 billion. Premier also updated its FY25 guidance to 1.16-1.28 EPS.

Premier Stock Performance

PINC opened at $20.23 on Wednesday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.82 and a current ratio of 0.93. The company has a market cap of $2.12 billion, a PE ratio of 31.61, a price-to-earnings-growth ratio of 6.47 and a beta of 0.42. The stock has a 50-day moving average of $19.31 and a 200-day moving average of $20.19. Premier has a 52-week low of $17.95 and a 52-week high of $26.07.

Premier Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Sunday, September 15th. Stockholders of record on Sunday, September 1st will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.15%. The ex-dividend date of this dividend is Friday, August 30th. Premier’s dividend payout ratio (DPR) is currently 131.25%.

Analysts Set New Price Targets

Several equities analysts have issued reports on the company. Robert W. Baird cut their price objective on Premier from $25.00 to $22.00 and set a neutral rating for the company in a research report on Wednesday, May 8th. JPMorgan Chase & Co. lowered their price target on shares of Premier from $23.00 to $21.00 and set a neutral rating for the company in a research report on Tuesday, May 28th. Piper Sandler cut their price objective on shares of Premier from $24.00 to $22.00 and set a neutral rating on the stock in a report on Wednesday, May 8th. StockNews.com raised shares of Premier from a hold rating to a buy rating in a report on Thursday, May 9th. Finally, Canaccord Genuity Group reiterated a hold rating and set a $21.00 target price (down previously from $27.00) on shares of Premier in a research report on Wednesday, May 8th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Premier currently has a consensus rating of Hold and an average target price of $23.50.

Insider Buying and Selling

In other Premier news, General Counsel David L. Klatsky sold 13,339 shares of Premier stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $18.55, for a total value of $247,438.45. Following the sale, the general counsel now owns 92,001 shares of the company’s stock, valued at approximately $1,706,618.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Andy Brailo sold 13,318 shares of the business’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $19.00, for a total value of $253,042.00. Following the sale, the insider now owns 98,427 shares of the company’s stock, valued at $1,870,113. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, General Counsel David L. Klatsky sold 13,339 shares of the stock in a transaction on Monday, June 10th. The stock was sold at an average price of $18.55, for a total transaction of $247,438.45. Following the transaction, the general counsel now owns 92,001 shares of the company’s stock, valued at approximately $1,706,618.55. The disclosure for this sale can be found here. In the last ninety days, insiders sold 132,886 shares of company stock valued at $2,615,946. Company insiders own 0.85% of the company’s stock.

Premier Company Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.